StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$2.02−0.02 (-0.98%)

Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –

Compugen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was $31.63M, down 36.2% from the year before. The highest annual figure on record is $49.60M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$31.63M-36.2%
FY2024Dec 31, 2024$49.60M–
FY2023Dec 31, 2023-$35.89M–
FY2022Dec 31, 2022-$34.11M–
FY2021Dec 31, 2021-$22.69M–
FY2020Dec 31, 2020-$28.32M–
FY2019Dec 31, 2019-$27.89M–
FY2018Dec 31, 2018-$13.29M–
FY2017Dec 31, 2017-$30.66M–
FY2016Dec 31, 2016-$19.82M–
FY2015Dec 31, 2015-$25.61M–
FY2014Dec 31, 2014-$11.15M–
FY2013Dec 31, 2013-$6.44M–
FY2012Dec 31, 2012-$10.85M–
FY2011Dec 31, 2011-$9.25M–
FY2010Dec 31, 2010-$4.28M–
FY2009Dec 31, 2009-$7.45M–

More Compugen figures

See a number that looks wrong?